|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400086545 |
|
最近更新日期: Date of Last Refreshed on: |
2024-07-04 17:42:47 |
|
注册时间: Date of Registration: |
2024-07-04 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
代谢综合征患者血清尿酸水平对右心功能的影响 |
|
Public title: |
Effect of serum uric acid level on right ventricular and right atria function in patients with metabolic syndrome |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
代谢综合征患者血清尿酸水平对右心功能的影响 |
|
Scientific title: |
Effect of serum uric acid level on right ventricular and right atria function in patients with metabolic syndrome |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李初炜 |
研究负责人: |
孙菲菲 |
|
Applicant: |
Chuwei Li |
Study leader: |
Feifei Sun |
|
申请注册联系人电话: Applicant telephone: |
+86 187 4017 0147 |
研究负责人电话:
Study leader's |
+86 189 4025 7623 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1293815015@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
sffecho0120@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
辽宁省沈阳市和平区三好街36号 |
研究负责人通讯地址: |
辽宁省沈阳市和平区三好街36号 |
|
Applicant address: |
36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, China |
Study leader's address: |
36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国医科大学附属盛京医院 |
||
|
Applicant's institution: |
Shengjing Hospital of China Medical University |
||
|
研究负责人所在单位: |
中国医科大学附属盛京医院 |
||
|
Affiliation of the Leader: |
Shengjing Hospital of China Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024PS1152K |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医科大学附属盛京医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Shengjing Hospital Affiliated to China Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-06-04 00:00:00 | ||
|
伦理委员会联系人: |
郭传骥 |
||
|
Contact Name of the ethic committee: |
Chuanji Guo |
||
|
伦理委员会联系地址: |
沈阳市和平区三好街36号 |
||
|
Contact Address of the ethic committee: |
36 Sanhao Street, Heping District, Shenyang City |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24 966 151 0027 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国医科大学附属盛京医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shengjing Hospital of China Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省沈阳市和平区三好街36号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
36 Sanhao Street, Heping District, Shenyang City, Liaoning Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
辽宁省科学技术厅,医工交叉联合基金(2022-YGJC-55);沈阳市中青年科技创新人才支持项目[RC210226];中国医科大学附属盛京医院“345”人才支持计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Liaoning Provincial Department of Science and Technology, Medical-Industrial Crossover Joint Fund [2022-YGJC-55]; Young and Middle-aged Scientific and Technological Innovation Talent Support Project of Shenyang City [RC210226]; The 345 Talent Project of Shengjing Hospital of China Medical University |
||||||||||||||||||||||
|
研究疾病: |
代谢综合征 |
||||||||||||||||||||||
|
Target disease: |
Metabolic Syndrome |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
识别导致心肌功能障碍的因素对于更好地了解病理生理学并帮助制定预防代谢综合征相关心力衰竭的治疗策略至关重要,本研究旨在评估无任何已知心血管疾病病史的患有代谢综合征或其组成成分的患者血清尿酸水平对右心功能有何影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Identifying factors that contribute to myocardial dysfunction is critical to better understand the pathophysiology and help develop therapeutic strategies to prevent metabolic syndrome related heart failure. The purpose of the study was to evaluate the impact of serum uric acid levels on right ventricular function in patients with metabolic syndrome or its components without any known history of cardiovascular disease. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
患有以下一种或一种以上疾病的患者: 1.腹部型肥胖 2.高血压 3.高血糖 4.高血脂 |
||||||||||||||||||||||
|
Inclusion criteria |
Patients with one or more of the following conditions: 1.Abdominal obesity 2.Hypertension 3.Hyperglycemia 4.Hyperlipidemia |
||||||||||||||||||||||
|
排除标准: |
1.冠状动脉疾病 2.心力衰竭 3.心房颤动 4.既往脑血管损伤 5.先天性心脏病 6.中度至重度瓣膜性心脏 7.其他慢性疾病,如肺动脉高压、阻塞性肺疾病、肝硬化、肿瘤疾病和肾衰竭。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Coronary artery disease 2.Heart failure 3.Atrial ?brillation 4.Previous cerebrovascular insult 5.Congenital heart disease 6.Moderate or severe valvular heart disease 7.Other chronic diseases, such as pulmonary hypertension, obstructive pulmonary disease, cirrhosis of the liver, neoplastic disease and kidney failure. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-07-04 00:00:00至 To 2025-07-04 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-07-04 00:00:00 至 To 2024-08-27 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
暂无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not yet determined |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
原始记录以及采集图像分别由专人负责归档管理,数据录入SPSS和EXCEL表格数据库。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The original records, case records and images are archived and managed by dedicated personnel, and the data is entered into SPSS and EXCEL form databases. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |